Your browser doesn't support javascript.
loading
Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.
Al-Shamsi, Humaid O; Jones, Jeremy; Fahmawi, Yazan; Dahbour, Ibrahim; Tabash, Aziz; Abdel-Wahab, Reham; Abousamra, Ahmed O S; Shaw, Kenna R; Xiao, Lianchun; Hassan, Manal M; Kipp, Benjamin R; Kopetz, Scott; Soliman, Amr S; McWilliams, Robert R; Wolff, Robert A.
Afiliação
  • Al-Shamsi HO; Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA;; Khalifa Bin Zayed Al Nahyan Foundation, Abu Dhabi, United Arab Emirates;; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, the University of Texas MD
  • Jones J; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Fahmawi Y; Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dahbour I; Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tabash A; Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Abdel-Wahab R; Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA;; Clinical Oncology Department, Assiut University, Assiut, Egypt.
  • Abousamra AO; Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shaw KR; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Xiao L; Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hassan MM; Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kipp BR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kopetz S; Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Soliman AS; Department of Epidemiology, the University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • McWilliams RR; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Wolff RA; Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
J Gastrointest Oncol ; 7(6): 882-902, 2016 Dec.
Article em En | MEDLINE | ID: mdl-28078112
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Gastrointest Oncol Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Gastrointest Oncol Ano de publicação: 2016 Tipo de documento: Article